Tadaflo 5 mg is used for treating various conditions such as Erectile Dysfunction, Benign Prostatic Hyperplasia, and Pulmonary Arterial Hypertension. The common active ingredient of this medicine is tadalafil which is an inhibitor of phosphodiesterase type 5 (PDE5). Mainly this medicine is given to people suffering from ED.
The inability to achieve or maintain an erection that is adequate for sexual intercourse is known as erectile dysfunction. PDE5 is the enzyme that breaks down cyclic guanosine monophosphate (cGMP). Tadalafil, the active ingredient in Tadaflo 5 mg, functions by blocking the activity of cGMP. cGMP is a molecule that plays an important role in expanding blood vessels into the penis to enhance blood flow and promote an erection.
Tadaflo 5 mg is considered as lowest dose among all the Tadaflo medications. This lower dose is generally administered to those individuals who require the intake of medicine every 24 hours. Often, low doses show lessen side effects in comparison to the higher doses. Keep in mind, that Tadaflo is a prescription-only drug and should be taken under the guidance of a healthcare professional.
The effectiveness of the drug may vary for every individual. Some of the major factors that affect the efficacy of the drug for people are age, body weight and height, medical history, and response to the drug. Doctors mostly suggest individuals with ED should take Tadaflo 5 mg medicine 30 minutes before an intimate session. In around 1 hour, people can experience the effects of the drug. The peak effects of medicine stay active for about 18 hours.
Tadaflo 5 mg is available in the form of oral tablets. Along with all the benefits of the drug, various side effects are also associated with it. Mentioned below are some of the common adverse effects.
Indigestion
Swelling of hands and legs
The problem occurring while breathing
Runny and stuffy nose
Back pain
Facial flushing
Nasal congestion
Nasal bleeds
Back pain
Pain in legs and arms
Ringing in ears
Abdomen pain.
Reviews
There are no reviews yet.